Status:
COMPLETED
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
Lead Sponsor:
AstraZeneca
Conditions:
Bipolar Depression
Eligibility:
All Genders
18-50 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to compare the sedation profile one hour after dose administration between Seroquel IR and Seroquel XR.
Eligibility Criteria
Inclusion
- DSM-IV-TR documented bipolar I or bipolar II, most recent episode depressed
- Outpatient status as enrollment
Exclusion
- Other than bipolar disorder under study, patients must not have another current, major disorder that is symptomatic or has required treatment within 6 months of enrollment.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT00926393
Start Date
June 1 2009
End Date
August 1 2009
Last Update
May 11 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.